05:57 PM EST, 12/17/2025 (MT Newswires) -- Patrick Burnett, Executive Vice President and Chief Medical Officer, on December 15, 2025, sold 11,500 shares in Arcutis Biotherapeutics ( ARQT ) for $332,851. Following the Form 4 filing with the SEC, Burnett has control over a total of 98,307 common shares of the company, with 98,307 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1787306/000174198725000010/xslF345X05/wk-form4_1766012033.xml